Cargando…

A Precision Strategy to Cure Renal Cell Carcinoma by Targeting Transglutaminase 2

In a recent report, no significance of transglutaminase 2 (TGase 2) was noted in the analyses of expression differences between normal and clear cell renal cell carcinoma (ccRCC), although we found that knock down of TGase 2 induced significant p53-mediated cell death in ccRCC. Generally, to find ef...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Soo-Youl, Keillor, Jeffrey W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7177245/
https://www.ncbi.nlm.nih.gov/pubmed/32260198
http://dx.doi.org/10.3390/ijms21072493